Detalhe da pesquisa
1.
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
Eur J Nutr
; 60(6): 3043-3057, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33474638
2.
Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study.
Eur J Nutr
; 60(4): 1769-1780, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32857176
3.
Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile.
Int J Mol Sci
; 19(11)2018 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463312
4.
Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study.
Diagnostics (Basel)
; 11(6)2021 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199237
5.
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study.
J Clin Lipidol
; 14(6): 837-849.e2, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32962964
6.
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study.
Diagnostics (Basel)
; 10(11)2020 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171699
7.
Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease.
Nutrients
; 12(5)2020 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365683
8.
Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study.
Nutrients
; 11(10)2019 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623368
9.
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
Nutrients
; 11(10)2019 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652512
10.
Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
Nutrients
; 11(2)2019 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30717355